Home › Funds › Octagon Capital Advisors LP › DTIL

Octagon Capital Advisors LP position in DTIL

PRECISION BIOSCIENCES INC · Health Care

Octagon Capital Advisors LP reported holding 430,000 shares of DTIL (PRECISION BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 0.36% of its reported portfolio and ranking #24 among its reported holdings. Octagon Capital Advisors LP has disclosed DTIL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)430.00K sh
Reported value held$2.69M
Portfolio Weight0.36%
First reportedQ4 2025
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's DTIL position evolved

Octagon Capital Advisors LP first disclosed a stake in DTIL in Q4 2025 at 1,917,995 shares (US$8.0M). The position peaked in Q1 2026 at 2,236,732 shares, worth US$12.3M. Across 4 filings, Octagon Capital Advisors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 430,000 shares valued at US$2.7M — a reduction of -920,000 shares quarter over quarter.. Notable position changes include a 40% trim in Q2 2026 (shares fell 20% over the following quarter), a 68% trim in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.92M $7.98M New
Q1 2026 2.24M $12.30M Add
Q2 2026 1.35M $10.61M Reduce
Q3 2026 430.00K $2.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DTIL and 13F data

DTIL (PRECISION BIOSCIENCES INC) is a Health Care company. 47 other funds we track also report a position in DTIL — the largest reported positions include Lynx1 Capital Management LP (US$17.3M), Bleichroeder LP (US$12.6M), Empery Asset Management, LP (US$640K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DTIL

All DTIL fund holders →

FAQ

How long has Octagon Capital Advisors LP held DTIL?

Octagon Capital Advisors LP has disclosed DTIL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Octagon Capital Advisors LP's current position in DTIL?

As of Q3 2026, Octagon Capital Advisors LP holds 430.00K shares of DTIL (PRECISION BIOSCIENCES INC), valued at $2.69M, representing 0.36% of its reported portfolio and ranking #24.

Has Octagon Capital Advisors LP been buying or selling DTIL?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in DTIL. The position peaked in Q1 2026 at 2.24M shares.

Which other funds hold DTIL?

Other major institutional holders of DTIL include Lynx1 Capital Management LP, Bleichroeder LP, Empery Asset Management, LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.